FDA Inspection
Michael W. Harris, D.O.Michael W. Harris, D.O. – FDA Inspection, May 3, 2011
Record Details
This FDA Inspection record concerns Michael W. Harris, D.O., with an inspection on May 3, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Michael W. Harris, D.O.
- Inspection Date
- May 3, 2011
- Product Type
- Drugs
View Company Profile
ID · 1106171e-b2d5-4cd6-b9c8-4dda869a8ba5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 732501
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael W. Harris, D.O.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 15, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 29, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael W. Harris, D.O.
- FDA Inspection 1091037 - 2019-05-24
- FDA Inspection 959266 - 2015-12-15
- FDA Inspection 898295 - 2014-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.